InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Travere Therapeutics, Inc.

TVTX Clue Score50
United States Fiscal year ends December CIK 0001438533 Results filed 2 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

67
Insider
Date
Role
Action
Shares
Price
Amount
Timothy Coughlin
15 May 2026
Director
Sold on a plan
3,250
$43.49
$141.34K
Christopher R. Cline
6 May 2026
Chief Financial Officer
Sold on a plan
310
$43.95
$13.62K
Eric M Dube
6 May 2026
Chief Executive Officer
Sold on a plan
22,500
$43.95
$988.88K
Jula Inrig
6 May 2026
Chief Medical Officer
Sold on a plan
311
$43.95
$13.67K
Elizabeth E Reed
6 May 2026
Chief Legal Officer and GC
Sold on a plan
2,076
$43.95
$91.24K
William E. Rote
6 May 2026
Chief Research Officer
Sold on a plan
2,763
$43.95
$121.43K
Christopher R. Cline
5 May 2026
Chief Financial Officer
Sold on a plan
2,181
$46.65
$101.74K
Jula Inrig
5 May 2026
Chief Medical Officer
Sold on a plan
2,174
$46.65
$101.42K
Elizabeth E Reed
5 May 2026
Chief Legal Officer and GC
Sold on a plan
2,174
$46.65
$101.42K
William E. Rote
22 Apr 2026
Chief Research Officer
Sold on a plan
9,100
$39.09
$355.72K
Jula Inrig
15 Apr 2026
Chief Medical Officer
Sold on a plan
1,018
$42.61
$43.38K
Christopher R. Cline
15 Apr 2026
Chief Financial Officer
Sold on a plan
1,014
$42.61
$43.21K
Elizabeth E Reed
15 Apr 2026
Chief Legal Officer and GC
Sold on a plan
1,559
$42.53
$66.30K
Elizabeth E Reed
15 Apr 2026
Chief Legal Officer and GC
Sold on a plan
5,226
$41.62
$217.51K
Eric M Dube
15 Apr 2026
Chief Executive Officer
Sold on a plan
20
$42.66
$853.20
Eric M Dube
15 Apr 2026
Chief Executive Officer
Sold on a plan
7,165
$41.75
$299.14K
Eric M Dube
15 Apr 2026
Chief Executive Officer
Sold on a plan
56,815
$41.01
$2.33M
Jula Inrig
14 Apr 2026
Chief Medical Officer
Sold on a plan
7,215
$41.93
$302.52K
Christopher R. Cline
14 Apr 2026
Chief Financial Officer
Sold on a plan
7,239
$41.93
$303.52K
Christopher R. Cline
14 Apr 2026
Chief Financial Officer
Sold on a plan
9
$41.07
$369.63
Christopher R. Cline
13 Apr 2026
Chief Financial Officer
Sold on a plan
65
$28.85
$1.88K
Elizabeth E Reed
4 Feb 2026
Chief Legal Officer and GC
Sold on a plan
509
$32.74
$16.66K
Elizabeth E Reed
4 Feb 2026
Chief Legal Officer and GC
Sold on a plan
2,485
$32.07
$79.69K
Christopher R. Cline
4 Feb 2026
Chief Financial Officer
Sold on a plan
110
$32.90
$3.62K
Christopher R. Cline
4 Feb 2026
Chief Financial Officer
Sold on a plan
1,635
$32.14
$52.55K
Jula Inrig
4 Feb 2026
Chief Medical Officer
Sold on a plan
232
$32.85
$7.62K
Jula Inrig
4 Feb 2026
Chief Medical Officer
Sold on a plan
1,547
$32.11
$49.67K
William E. Rote
3 Feb 2026
Chief Research Officer
Sold on a plan
12,446
$32.87
$409.10K
Eric M Dube
3 Feb 2026
Chief Executive Officer
Sold on a plan
33,635
$32.70
$1.10M
Eric M Dube
3 Feb 2026
Chief Executive Officer
Sold on a plan
66,452
$32.06
$2.13M
Jula Inrig
6 Jan 2026
Chief Medical Officer
Sold on a plan
445
$37.75
$16.80K
Jula Inrig
5 Jan 2026
Chief Medical Officer
Sold on a plan
2,031
$40.18
$81.61K
Sandra Calvin
24 Dec 2025
SVP, Chief Accounting Officer
Sold on a plan
7,402
$40.00
$296.08K
Peter Heerma
24 Dec 2025
Chief Commercial Officer
Sold on a plan
4,980
$40.00
$199.20K
Sandra Calvin
15 Dec 2025
SVP, Chief Accounting Officer
Sold on a plan
2,910
$36.00
$104.76K
Peter Heerma
31 Oct 2025
Chief Commercial Officer
Sold on a plan
5,591
$35.00
$195.69K
Peter Heerma
28 Oct 2025
Chief Commercial Officer
Sold on a plan
2,662
$30.00
$79.86K
Christopher R. Cline
4 Sep 2025
Chief Financial Officer
Sold on a plan
119
$19.71
$2.35K
Christopher R. Cline
3 Sep 2025
Chief Financial Officer
Sold on a plan
454
$18.20
$8.26K
Christopher R. Cline
27 Aug 2025
Chief Financial Officer
Sold on a plan
470
$17.31
$8.14K
Jula Inrig
1 Jul 2025
Chief Medical Officer
Sold on a plan
815
$14.65
$11.94K
Elizabeth E Reed
5 May 2025
Chief Legal Officer and GC
Sold on a plan
4,920
$21.05
$103.57K
William E. Rote
5 May 2025
Chief Research Officer
Sold on a plan
3,198
$21.05
$67.32K
Eric M Dube
5 May 2025
Chief Executive Officer
Sold on a plan
18,924
$21.05
$398.35K
Peter Heerma
12 Feb 2025
Chief Commercial Officer
Sold on a plan
2,568
$23.53
$60.43K
Elizabeth E Reed
12 Feb 2025
SVP, GC & Corporate Secretary
Sold on a plan
8,000
$23.53
$188.24K
William E. Rote
12 Feb 2025
Senior Vice President, R&D
Sold on a plan
5,200
$23.53
$122.36K
Eric M Dube
11 Feb 2025
Chief Executive Officer
Sold on a plan
11,375
$24.04
$273.46K
Peter Heerma
11 Feb 2025
Chief Commercial Officer
Sold on a plan
3,074
$25.00
$76.85K
Jula Inrig
4 Feb 2025
Chief Medical Officer
Sold on a plan
1,066
$20.11
$21.44K
Jula Inrig
3 Feb 2025
Chief Medical Officer
Sold on a plan
4,207
$20.12
$84.64K
Eric M Dube
3 Feb 2025
Chief Executive Officer
Sold on a plan
50,691
$20.21
$1.02M
Elizabeth E Reed
3 Feb 2025
SVP, GC & Corporate Secretary
Sold on a plan
8,951
$19.78
$177.05K
William E. Rote
3 Feb 2025
Senior Vice President, R&D
Sold on a plan
8,951
$19.78
$177.05K
Elizabeth E Reed
22 Jan 2025
SVP, GC & Corporate Secretary
Sold on a plan
2,437
$19.46
$47.42K
Eric M Dube
22 Jan 2025
Chief Executive Officer
Sold on a plan
10,736
$19.46
$208.92K
William E. Rote
22 Jan 2025
Senior Vice President, R&D
Sold on a plan
2,437
$19.46
$47.42K
Jula Inrig
6 Jan 2025
Chief Medical Officer
Sold on a plan
440
$18.76
$8.25K
Jula Inrig
3 Jan 2025
Chief Medical Officer
Sold on a plan
2,066
$19.10
$39.46K
Jula Inrig
10 Sep 2024
Chief Medical Officer
Sold on a plan
684
$12.98
$8.88K
Eric M Dube
9 Sep 2024
Chief Executive Officer
Sold on a plan
21,125
$11.52
$243.36K
Elizabeth E Reed
9 Sep 2024
SVP, GC & Corporate Secretary
Sold on a plan
4,387
$11.52
$50.54K
William E. Rote
9 Sep 2024
Senior Vice President, R&D
Sold on a plan
4,387
$11.52
$50.54K
Sandra Calvin
11 May 2023
SVP, Chief Accounting Officer
Sold on a plan
122
$16.12
$1.97K
Sandra Calvin
10 May 2023
SVP, Chief Accounting Officer
Sold on a plan
436
$16.59
$7.23K
William E. Rote
10 May 2023
Senior Vice President, R&D
Sold on a plan
825
$16.59
$13.69K
Elizabeth E Reed
10 May 2023
SVP, GC & Corporate Secretary
Sold on a plan
825
$16.59
$13.69K
Showing 250 of 436 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 424
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 67
Sales straight out of an exercise 100
Sales at will 267
Transactions with no price 0
Shares from compensation/vesting 4,899,673
Sales filed before the plan box existed 219
History held since 26 Dec 2012